Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)
Accessed on May 14, 2025 at Rizvi, A
Medical Writing, Editorial, and Other Assistance Medical writing support was provided by Kate Silverthorne, PhD, CMPP, a contract writer working on behalf of OPEN Health Communications, and James Parkinson, PhD, CMPP, of Apollo, OPEN Health Communications, and funded by Novo Nordisk Ltd., under the direction of the authors and in accordance with Good Publication Practice (GPP) guidelines (www.ismpp.org/gpp-2022)
Most patients experience mild nausea, especially when starting GLP-1 medications or increasing doses, though this typically improves within 2-4 weeks as your body adjusts to the medication
These medications are self-administered shots, taken once a week, and have a long history of safety and effectiveness